vTv Therapeutics Inc. (VTVT) — insider trading
Health Care · NASDAQ
vTv Therapeutics Inc. (VTVT) has 22 reported SEC Form 4 insider transactions in our data (latest 2026-06-26).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-26 | Phillips Anne M. | Director | Grant / award / vesting (derivative) | 6,000 | $35.08 | $210.5K | Form 4 |
| 2026-06-26 | Al-Marzooqi Fahed | Director | Grant / award / vesting (derivative) | 6,000 | $35.08 | $210.5K | Form 4 |
| 2026-06-26 | AKKARAJU SRINIVAS | Director | Grant / award / vesting (derivative) | 6,000 | $35.08 | $210.5K | Form 4 |
| 2026-06-26 | SPIEGELMAN DANIEL K | Director | Grant / award / vesting (derivative) | 6,000 | $35.08 | $210.5K | Form 4 |
| 2026-06-26 | BAKER BROS. ADVISORS LP; 667, L.P.; Baker Brothers Life Sciences LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC | Director | Grant / award / vesting (derivative) | 6,000 | — | $0 | Form 4 |
| 2026-06-26 | BAKER BROS. ADVISORS LP; 667, L.P.; Baker Brothers Life Sciences LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC | Director | Grant / award / vesting (derivative) | 6,000 | — | $0 | Form 4 |
| 2026-02-17 | SEKHRI PAUL J | Director, Officer (Pres, CEO and Exec Chairperson) | Grant / award / vesting (derivative) | 140,000 | $36.92 | $5.17M | Form 4 |
| 2026-02-17 | Tung Michael Stephen | Officer (EVP & CFO) | Grant / award / vesting (derivative) | 44,969 | $36.92 | $1.66M | Form 4 |
| 2025-09-22 | AKKARAJU SRINIVAS | Director | Grant / award / vesting (derivative) | 983,214 | — | — | Form 4 |
| 2025-09-22 | AKKARAJU SRINIVAS | Director | Grant / award / vesting (derivative) | 877,214 | — | — | Form 4 |
| 2025-09-22 | AKKARAJU SRINIVAS | Director | Grant / award / vesting | 106,000 | $15.27 | $1.62M | Form 4 |
| 2025-09-03 | BAKER BROS. ADVISORS LP; 667, L.P.; Baker Brothers Life Sciences LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC | Director | Grant / award / vesting (derivative) | 2,400,605 | — | — | Form 4 |
| 2025-09-03 | BAKER BROS. ADVISORS LP; 667, L.P.; Baker Brothers Life Sciences LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC | Director | Grant / award / vesting (derivative) | 221,452 | — | — | Form 4 |
| 2025-09-03 | BAKER BROS. ADVISORS LP; 667, L.P.; Baker Brothers Life Sciences LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC | Director | Grant / award / vesting (derivative) | 2,353,913 | — | — | Form 4 |
| 2025-09-03 | BAKER BROS. ADVISORS LP; 667, L.P.; Baker Brothers Life Sciences LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC | Director | Grant / award / vesting (derivative) | 217,144 | — | — | Form 4 |
| 2025-09-03 | BAKER BROS. ADVISORS LP; 667, L.P.; Baker Brothers Life Sciences LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC | Director | Grant / award / vesting | 46,692 | — | — | Form 4 |
| 2025-09-03 | BAKER BROS. ADVISORS LP; 667, L.P.; Baker Brothers Life Sciences LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC | Director | Grant / award / vesting | 4,308 | — | — | Form 4 |
| 2025-09-03 | AKKARAJU SRINIVAS | Director | Grant / award / vesting (derivative) | 655,523 | — | — | Form 4 |
| 2025-09-03 | AKKARAJU SRINIVAS | Director | Grant / award / vesting (derivative) | 655,523 | — | — | Form 4 |
| 2025-06-10 | SPIEGELMAN DANIEL K | Director | Grant / award / vesting (derivative) | 4,000 | $16.59 | $66.4K | Form 4 |
| 2025-06-10 | BAKER BROS. ADVISORS LP; 667, L.P.; Baker Brothers Life Sciences LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC | Director | Grant / award / vesting (derivative) | 4,000 | — | $0 | Form 4 |
| 2025-06-10 | BAKER BROS. ADVISORS LP; 667, L.P.; Baker Brothers Life Sciences LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC | Director | Grant / award / vesting (derivative) | 4,000 | — | $0 | Form 4 |
Ask the chat about VTVT's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: vTv Therapeutics Inc. (VTVT).
Last updated 2026-06-26 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.